Food Allergy Research & Education

Food Allergy Research & Education
Founded2012; established through merger of the Food Allergy & Anaphylaxis Network (est.1991) and the Food Allergy Initiative (est. 1998)
FocusFood allergies
Location
Area served
United States
MethodResearch, Education, Awareness, Advocacy
CEO
Sung Poblete
Revenue$18,707,655 USD (for year ending December 31, 2020)
Websitewww.foodallergy.org

Food Allergy Research & Education (FARE) is a non-profit, private organization dedicated to food allergy awareness, research, education, and advocacy. FARE's goal is to enhance the lives of people with food allergies by providing support and resources to help them live safe yet productive lives. FARE also includes information for people without food allergies, who are looking to not only be respectful of others but also become more educated and gain more awareness regarding healthcare and treatments. The organization provides information, programs, and resources about food allergies and anaphylaxis, a severe, potentially life-threatening allergic reaction. Working on behalf of more than 32 million Americans who have potentially life-threatening food allergies, FARE's mission is to improve the quality of life and health of those with food allergies and to provide hope for the development of new treatments and diagnostics.

FARE formed in 2012 through the merger of two food allergy patient advocacy organizations: the Food Allergy & Anaphylaxis Network (FAAN), a nonprofit organization founded in 1991 by whose goal was to provide information about food allergies during a time when this information was limited and the Food Allergy Initiative (FAI), founded in 1998 by concerned parents and grandparents who were committed to advancing food allergy research. The new organization combined FAAN's expertise in patient education and government lobbying with FAI's leadership in research funding. As FARE marks its 10th anniversary in 2022, the organization's donor supported investments in food allergy research, education, and advocacy totaled $100 million.